1006462-23-2 Usage
Uses
Used in Pharmaceutical Applications:
1-(2,2-difluoroethyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid is used as a building block in the pharmaceutical industry for the development of new drugs. Its unique structure and functional groups contribute to its potential as a key component in the synthesis of novel therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(2,2-difluoroethyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid is utilized as a valuable compound for designing and synthesizing new drug candidates. Its fluorinated nature and specific functional groups can enhance the pharmacokinetic and pharmacodynamic properties of the resulting drug molecules.
Used in Organic Syntheses:
1-(2,2-difluoroethyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid is employed as a key intermediate in various organic synthesis processes. Its unique structure allows for the creation of a wide range of chemical products, including those with potential applications in the chemical, pharmaceutical, and materials science industries.
Used in Materials Science:
The presence of fluorine atoms in the molecule of 1-(2,2-difluoroethyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid endows it with unique physicochemical properties. This makes it a potentially useful compound for research and development in materials science, where it could be applied in the creation of novel materials with specific characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 1006462-23-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,6,4,6 and 2 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1006462-23:
(9*1)+(8*0)+(7*0)+(6*6)+(5*4)+(4*6)+(3*2)+(2*2)+(1*3)=102
102 % 10 = 2
So 1006462-23-2 is a valid CAS Registry Number.
1006462-23-2Relevant academic research and scientific papers
KCNT1 INHIBITORS AND METHODS OF USE
-
, (2020/11/23)
The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
